News | February 09, 2022
Glenmark launches nasal spray to treat Covid-19
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Pegfilgrastim is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving chemotherapy
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
The drug will be marketed under the brand name Molnaflu
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The company will donate 5000 nebulizers to primary health care centres in rural India
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Subscribe To Our Newsletter & Stay Updated
